GB1556569A - 1,5-disubstituted - 2 - pyrrolidones - Google Patents

1,5-disubstituted - 2 - pyrrolidones

Info

Publication number
GB1556569A
GB1556569A GB33002/77A GB3300277A GB1556569A GB 1556569 A GB1556569 A GB 1556569A GB 33002/77 A GB33002/77 A GB 33002/77A GB 3300277 A GB3300277 A GB 3300277A GB 1556569 A GB1556569 A GB 1556569A
Authority
GB
United Kingdom
Prior art keywords
pyrrolidones
disubstituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB33002/77A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of GB1556569A publication Critical patent/GB1556569A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
GB33002/77A 1976-08-06 1977-08-05 1,5-disubstituted - 2 - pyrrolidones Expired GB1556569A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71236276A 1976-08-06 1976-08-06

Publications (1)

Publication Number Publication Date
GB1556569A true GB1556569A (en) 1979-11-28

Family

ID=24861795

Family Applications (2)

Application Number Title Priority Date Filing Date
GB43588/78A Expired GB1556570A (en) 1976-08-06 1977-08-05 1,5-disubstituted - 2 - pyrrolidones
GB33002/77A Expired GB1556569A (en) 1976-08-06 1977-08-05 1,5-disubstituted - 2 - pyrrolidones

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GB43588/78A Expired GB1556570A (en) 1976-08-06 1977-08-05 1,5-disubstituted - 2 - pyrrolidones

Country Status (31)

Country Link
JP (2) JPS5321159A (ru)
AR (1) AR217080A1 (ru)
AT (1) AT362887B (ru)
AU (1) AU508007B2 (ru)
BE (1) BE857506A (ru)
BG (1) BG31073A3 (ru)
CA (1) CA1077948A (ru)
CH (1) CH624934A5 (ru)
CS (1) CS221269B2 (ru)
DD (2) DD143768A5 (ru)
DE (1) DE2735904A1 (ru)
DK (1) DK352077A (ru)
ES (2) ES461388A1 (ru)
FI (1) FI70009C (ru)
FR (1) FR2369260A1 (ru)
GB (2) GB1556570A (ru)
GR (1) GR68688B (ru)
HU (1) HU180273B (ru)
IE (1) IE45505B1 (ru)
IL (1) IL52615A (ru)
LU (1) LU77936A1 (ru)
NL (1) NL7708637A (ru)
NO (1) NO772752L (ru)
NZ (1) NZ184806A (ru)
PH (1) PH17398A (ru)
PL (2) PL112931B1 (ru)
PT (1) PT66891B (ru)
SE (1) SE423813B (ru)
SU (3) SU703016A3 (ru)
YU (1) YU192577A (ru)
ZA (1) ZA774704B (ru)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1132086A2 (en) * 2000-01-31 2001-09-12 Pfizer Products Inc. Use of prostaglandin (PGE2) receptor 4 (EP4) selective agonists for the treatment of acute and chronic renal failure
WO2003077910A1 (en) * 2002-03-18 2003-09-25 Pfizer Products Inc. Methods of treatment with selective ep4 receptor agonists
EP1586564A1 (en) * 2003-01-21 2005-10-19 Ono Pharmaceutical Co., Ltd. 8-azaprostaglandin derivatives and medicinal uses thereof

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5695569A (en) * 1979-12-27 1981-08-03 Canon Inc Forming method for bar lens sphere face
US4321201A (en) * 1980-09-22 1982-03-23 E. I. Du Pont De Nemours And Company Optically active tert-alkyl 7-(2-oxo-5-carbonyloxypyrrolidinyl) heptanoates
JPS59137224A (ja) * 1983-01-25 1984-08-07 Mitsubishi Electric Corp 電気鉄道用き電電圧補償装置
WO2002024647A1 (fr) * 2000-09-21 2002-03-28 Ono Pharmaceutical Co., Ltd. Agonistes du recepteur de l'ep4 comprenant comme principe actif des derives de la 8-azaprostaglandine
CN1476429A (zh) * 2000-11-27 2004-02-18 �Ʒ� 治疗骨质疏松的ep4受体选择性激动剂
WO2003009872A1 (en) * 2001-07-23 2003-02-06 Ono Pharmaceutical Co., Ltd. Remedies for diseases with bone mass loss having ep4 agonist as the active ingredient
US6573294B1 (en) * 2002-05-14 2003-06-03 Allergan, Inc. 8-azaprostaglandin analogs as agents for lowering intraocular pressure

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1386146A (en) * 1972-05-03 1975-03-05 Ici Ltd Cyclopentane derivatives
JPS511460A (en) * 1974-06-24 1976-01-08 Tanabe Seiyaku Co 22 piroridonjudotaino seiho
JPS514166A (ja) * 1974-06-28 1976-01-14 Tanabe Seiyaku Co 22piroridonjudotaino seiho
US3975399A (en) * 1974-08-06 1976-08-17 E. I. Du Pont De Nemours And Company 1,5-Disubstituted-2-pyrrolidinones, -3-pyrrolin-2-ones, and -4-pyrrolin-2-ones
DE2528664A1 (de) * 1975-06-27 1977-01-13 Hoechst Ag Pyrrolidone und verfahren zu ihrer herstellung

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1132086A2 (en) * 2000-01-31 2001-09-12 Pfizer Products Inc. Use of prostaglandin (PGE2) receptor 4 (EP4) selective agonists for the treatment of acute and chronic renal failure
EP1132086A3 (en) * 2000-01-31 2002-01-09 Pfizer Products Inc. Use of prostaglandin (PGE2) receptor 4 (EP4) selective agonists for the treatment of acute and chronic renal failure
US6610719B2 (en) 2000-01-31 2003-08-26 Pfizer Inc. Use of prostaglandin (PGE2) receptor a (EP4) selective agonists for the treatment of acute and chronic renal failure
WO2003077910A1 (en) * 2002-03-18 2003-09-25 Pfizer Products Inc. Methods of treatment with selective ep4 receptor agonists
EP1586564A1 (en) * 2003-01-21 2005-10-19 Ono Pharmaceutical Co., Ltd. 8-azaprostaglandin derivatives and medicinal uses thereof
EP1586564A4 (en) * 2003-01-21 2008-04-30 Ono Pharmaceutical Co 8-AZAPROSTAGLANDIN DERIVATIVES AND THEIR MEDICAL USE

Also Published As

Publication number Publication date
ES471349A1 (es) 1979-09-16
PL112931B1 (en) 1980-11-29
YU192577A (en) 1983-04-30
ES461388A1 (es) 1978-12-01
SE423813B (sv) 1982-06-07
IL52615A (en) 1981-09-13
JPS585196B2 (ja) 1983-01-29
BE857506A (fr) 1978-02-06
NZ184806A (en) 1980-04-28
GR68688B (ru) 1982-02-01
FI70009B (fi) 1986-01-31
AT362887B (de) 1981-06-25
BG31073A3 (en) 1981-10-15
PT66891B (en) 1979-01-26
JPS5555161A (en) 1980-04-22
AU508007B2 (en) 1980-03-06
JPS5321159A (en) 1978-02-27
IL52615A0 (en) 1977-10-31
PT66891A (en) 1977-09-01
CH624934A5 (ru) 1981-08-31
FI70009C (fi) 1986-09-12
HU180273B (en) 1983-02-28
FI772376A (ru) 1978-02-07
AR217080A1 (es) 1980-02-29
JPS5531147B2 (ru) 1980-08-15
CA1077948A (en) 1980-05-20
GB1556570A (en) 1979-11-28
PH17398A (en) 1984-08-08
AU2751577A (en) 1979-02-08
ATA579477A (de) 1980-11-15
ZA774704B (en) 1978-06-28
LU77936A1 (ru) 1978-04-27
DD143768A5 (de) 1980-09-10
PL200124A1 (pl) 1978-05-22
SU850000A3 (ru) 1981-07-23
SU818480A3 (ru) 1981-03-30
NL7708637A (nl) 1978-02-08
DE2735904A1 (de) 1978-02-09
SE7708642L (sv) 1978-02-07
CS221269B2 (en) 1983-04-29
SU703016A3 (ru) 1979-12-05
DD136135A5 (de) 1979-06-20
FR2369260A1 (fr) 1978-05-26
DK352077A (da) 1978-02-07
NO772752L (no) 1978-02-07
FR2369260B1 (ru) 1982-02-12
IE45505L (en) 1978-02-06
IE45505B1 (en) 1982-09-08

Similar Documents

Publication Publication Date Title
PH13932A (en) 1,2,3,4-tetrahydro-napthalenes
SG30882G (en) 2-piperazinyl-6,7-dimethoxyquinazolines
GB1524917A (en) Gona-1,9(10)-dienes
NZ183143A (en) 2-aminoakyl-1,2-benzisothiazol 3-anes
GB1542361A (en) 1,4-benzo-dioxan derivatives
GB1556570A (en) 1,5-disubstituted - 2 - pyrrolidones
GB1542569A (en) 2-substituted-15-heteroaryl-16,17,18,19,20-pentanor-prostaglandins
IL52424A0 (en) 2,6-methano-2h-1-benzoxocins
AU2468877A (en) 1,4 -dicyanobytene
PH14105A (en) 1,2,3-thiadiazol-5-yl-ureas
ZA774515B (en) O-ethyl-s-n-propyl-o-2,2,2-trihaloethylphosphorothiolates(or thionothiolates)
GB1537635A (en) 15,16-dihydroxyprostaglandins
PH15728A (en) 1-amino-lower-alkyl-3,4-diphenyl-1h-pyrazoles
GB1538368A (en) 1,3,4,6-tetrathia and tetraselena-2,5-dihetero-pentalene compounds
IL53527A (en) N1-chloro-3,5-dinitrosulfanilamides
NZ184082A (en) 1-benzothiazol-2yl-1,3-imidazolidin-2-ones
GB1547729A (en) 1-phenyl-4-acetoxy-1,2-dihydroquinolin-2-ones
GB1554049A (en) 2-decarboxy-2-hydroxymethyl-13,14-didehydroprostaglandins
GB1541820A (en) 1,4-oxathianes
AU3178777A (en) Substituted 4,5-dihydroxy-imidazolidine-2-thiones
HK6182A (en) 2,3-dihydro-2-oxo-3-benzo(b)thiophenecarboxamides
GB1546347A (en) 5,11-diazatetracyclo-(6.2.2.02,7 04,9)-dodecanes
GB1554045A (en) 13,14-didehydroprostaglandins
ZA774088B (en) 2,5-dichloro-4-bromphenylazo-4-chloro-phenyl-sulphide
AU2808277A (en) 4,5-dichloro-3-arylimino-1,2-dithiolewes

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee